ProCE Banner Activity

Targets Affecting Cellular Communication and Survival: BRAF, MAPK, and HER2

Slideset Download
In this downloadable slideset, Axel Grothey, MD, discusses the current data on optimal treatment options for patients with cancer and BRAF, MAPK, or HER2 alterations.

Released: May 31, 2019

Expiration: May 29, 2020

Share

Faculty

Axel Grothey

Axel Grothey, MD

Professor, Oncology
Mayo Clinic
Rochester, Minnesota

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Array BioPharma

Bayer Healthcare Pharma

Blueprint Medicines

Celgene

Foundation Medicine

Genentech TEXT Only

Loxo Oncology

Merck Oncology

Puma Biotechnology, Inc.

Faculty Disclosure

Primary Author

Axel Grothey, MD

Professor, Oncology
Mayo Clinic
Rochester, Minnesota